February 27, 2018 / 12:49 PM / 3 months ago

BRIEF-Quentis Therapeutics Debuts With $48 Mln Series A Financing

Feb 27 (Reuters) - Quentis Therapeutics:

* QUENTIS THERAPEUTICS DEBUTS WITH $48 MILLION SERIES A FINANCING TO ADVANCE FIRST-IN-CLASS IMMUNOTHERAPIES TARGETING ENDOPLASMIC RETICULUM STRESS RESPONSE PATHWAYS

* QUENTIS THERAPEUTICS ​- ‍SERIES A FINANCING CO-LED BY VERSANT VENTURES, POLARIS PARTNERS, AFFILIATED LS POLARIS INNOVATION FUND Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below